comparemela.com

Latest Breaking News On - புஜிஃபில்ம் டோயாமா இரசாயன - Page 2 : comparemela.com

Govt has plenty of favipiravir

Govt has plenty of favipiravir 8 Hospitals benefiting, insists spokesman 8 Rows of beds on Monday fill Chaloem Phrakiat Sports Training Centre in Thung Kru district of Bangkok, where officials are running final checks on the field hospital, run by Erawan Hospital 3, before it is opened. (Photo: Arnun Chonmahatrakool) The government said on Monday it had secured a plentiful supply of favipiravir, a vital drug in the fight against Covid-19, and was urgently seeking permission to manufacture it itself. The Public Health Ministry was already supplying the antiviral medication medication to public and private hospitals around the country, said spokesman Anucha Burapachaisri.

Government has plenty of Favipiravir

Government has plenty of Favipiravir Government has plenty of Favipiravir THAILAND: The government said yesterday (May 3) it had secured a plentiful supply of Favipiravir, a vital drug in the fight against COVID-19, and was urgently seeking permission to manufacture it itself. Tuesday 4 May 2021, 09:11AM Rows of beds yesterday (May 3) fill Chaloem Phrakiat Sports Training Centre in Thung Kru district of Bangkok, where officials are running final checks on the field hospital, run by Erawan Hospital 3, before it is opened. Photo: Arnun Chonmahatrakool. The Public Health Ministry was already supplying the antiviral medication medication to public and private hospitals around the country, said spokesman Anucha Burapachaisri.

Public needs antiviral meds

Fujifilm starts anti-influenza drug trial in Japan to treat Covid-19

Fujifilm starts anti-influenza drug trial in Japan to treat Covid-19
clinicaltrialsarena.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from clinicaltrialsarena.com Daily Mail and Mail on Sunday newspapers.

Dr Reddy s arm seeks Canada nod for favipiravir tablets

Updated: Share Article AAA Dr. Reddy’s Laboratories Canada Inc., on behalf of a consortium, has filed an application with Health Canada seeking authorisation for Reeqonus (favipiravir) tablets for the acute treatment of mild to moderate COVID-19 adult patients. “Dr. Reddy’s is working closely with Health Canada for an expedited review of the drug application as speed to market is essential”, VP and general manager Vinod Ramachandran said. “If approved, it will launch the product soon for COVID-19 patients in Canada,” he added. Dr. Reddy’s Canada has filed the application on behalf of the consortium comprising Dr. Reddy’s Laboratories, Appili Therapeutics and Global Response Aid FZCO (GRA) under Health Canada’s interim order “respecting the importation, sale and advertising of drugs for use in relation to COVID-19.”

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.